| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data
|
Durie, Brian G. M.
|
|
|
41 |
5 |
p. 1923-1937
|
artikel
|
| 2 |
Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysis
|
Huang, Lidan
|
|
|
41 |
5 |
p. 1896-1910
|
artikel
|
| 3 |
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine
|
Kwan, Angela T. H.
|
|
|
41 |
5 |
p. 1983-1994
|
artikel
|
| 4 |
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review
|
Khasraw, Mustafa
|
|
|
41 |
5 |
p. 1815-1842
|
artikel
|
| 5 |
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause
|
Shiozawa, Aki
|
|
|
41 |
5 |
p. 1885-1895
|
artikel
|
| 6 |
Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis
|
Watkins, Claire
|
|
|
41 |
5 |
p. 2084-2085
|
artikel
|
| 7 |
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis
|
Alshahrani, Awad
|
|
|
41 |
5 |
p. 2083
|
artikel
|
| 8 |
Enhancing Drug Management, Cost Savings, and Staff Satisfaction in Anesthesiology: A Quality Improvement Project in a Chinese Tertiary Hospital
|
Xing, Xiaomin
|
|
|
41 |
5 |
p. 1953-1966
|
artikel
|
| 9 |
Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research
|
Karantzoulis, Stella
|
|
|
41 |
5 |
p. 2070-2082
|
artikel
|
| 10 |
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor
|
Salles, Gilles
|
|
|
41 |
5 |
p. 1938-1952
|
artikel
|
| 11 |
Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes
|
Hart, Rose J.
|
|
|
41 |
5 |
p. 2010-2027
|
artikel
|
| 12 |
Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study
|
Poon, Jiat Ling
|
|
|
41 |
5 |
p. 2028-2049
|
artikel
|
| 13 |
Perioperative and Long-Term Outcomes in Patients Undergoing Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Single-Center Experience
|
Nawrozi, Paimann
|
|
|
41 |
5 |
p. 1911-1922
|
artikel
|
| 14 |
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids
|
Daley-Yates, Peter T.
|
|
|
41 |
5 |
p. 1995-2009
|
artikel
|
| 15 |
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis
|
Chastek, Benjamin
|
|
|
41 |
5 |
p. 2086-2097
|
artikel
|
| 16 |
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study
|
Hong, Eun-Gyoung
|
|
|
41 |
5 |
p. 1967-1982
|
artikel
|
| 17 |
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review
|
Allegretti, Jessica R.
|
|
|
41 |
5 |
p. 1775-1794
|
artikel
|
| 18 |
Risk of Stroke in Real-World US Individuals with Type 2 Diabetes Receiving Semaglutide or a Dipeptidyl Peptidase 4 Inhibitor
|
Evans, Marc
|
|
|
41 |
5 |
p. 1843-1859
|
artikel
|
| 19 |
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study
|
Patriquin, Christopher J.
|
|
|
41 |
5 |
p. 2050-2069
|
artikel
|
| 20 |
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis
|
Culpepper, Larry
|
|
|
41 |
5 |
p. 1860-1884
|
artikel
|
| 21 |
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar
|
Gaylis, Norman
|
|
|
41 |
5 |
p. 1795-1814
|
artikel
|
Tijdschrift beschrijving